| Literature DB >> 16533391 |
Joachim Füllekrug1, Anna Shevchenko, Andrej Shevchenko, Kai Simons.
Abstract
BACKGROUND: MDCK cells derived from canine kidney are an important experimental model system for investigating epithelial polarity in mammalian cells. Monoclonal antibodies against apical gp114 and basolateral p58 have served as important tools in these studies. However, the molecular identity of these membrane glycoproteins has not been known.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16533391 PMCID: PMC1421407 DOI: 10.1186/1471-2091-7-8
Source DB: PubMed Journal: BMC Biochem ISSN: 1471-2091 Impact factor: 4.059
Figure 1A. WGA lectin affinity chromatography of MDCK cell membrane proteins. Bound proteins were eluted with 0.3 M N-acetylglucosamine, and stained by Coomassie blue after gel electrophoresis. L: aliquot of loaded protein preparation. E: eluted protein pattern (bracket indicates 114 kDa region). B. Flow chart for the purification of gp114. MDCK cell membranes were recovered by high-speed centrifugation from a postmitochondrial supernatant and partially solubilized by treatment with the non-ionic detergent Triton X-100 on ice. Soluble proteins were applied to immunoaffinity columns, and the eluted fractions concentrated by methanol-chloroform extraction-precipitation. Gp114 did not accumulate at the "protein" interface between aqueous and lipid phase but stayed in the hydrophilic supernatant. C. Enrichment of gp114. Lane 1 (A) corresponds to the methanolic phase after chloroform-methanol extraction of eluted proteins from the gp114 immunoaffinity column. Gp114 (arrowhead) is only weakly stained by Coomassie solution. Lane 2 (Ip) contains deglycosylated gp114 (arrowhead) after immunoprecipitation which was confirmed by Western blotting (not shown). The heavy chain of gp114 IgG is indicated by a white arrowhead.
Figure 2Nanoelectrospray spectrum of in-gel tryptic digest of gp114. Peaks labeled with Tr originated from the autolysis of trypsin; peaks labeled with IgG were identified as tryptic peptides from IgG antibodies by Mascot searches. Tandem mass spectra of other peaks were not matched by Mascot and were subjected to de novo interpretation (Figure 3). Inset: MALDI TOF peptide mass map of the tryptic digest of the gp114 band obtained from the gel shown in figure 1c, lane A. Deglycosylated gp114 gave the same spectrum (not shown). Peaks of autolysis products of trypsin labeled with Tr. Peaks of peptides originating from gp114 are designated with their m/z.
Figure 3Tandem mass spectrum of a precursor ion with m/z 656.8 and charge +4 (the charge was determined from mass difference between its isotopic peaks). The precursor ion is labeled with an asterisk. The spectrum was partially interpreted by considering precise mass differences between the adjacent fragment ions. Doubly charged fragment series rendered the sequence PGDTASLTWF which was further extended toward the N-terminus using very low abundant ions in the m/z range > 1100 (not shown), but the sequence of the two N-terminal amino acid residues remained ambiguous (VL or LV). It was possible to determine the C-terminal amino acid (K) and a short sequence stretch (TVLP) spaced from the C-terminal lysine by two or three unknown amino acid residues (X). Bridging between the sequence stretches PGDTASLTWF and TVLP could have been achieved by one of the three isobaric combination of amino acid residues, and the order of amino acid residues remained unknown. Hence the peptide might contain the sequence WF-QGET-VL, or WF-QEGT-VL, or WF-QADT-VL, or WF-QDAT-VL..., etc.
Peptide sequences of gp114 derived from MS/MS spectra. Peptide sequences from gp114 produced by the interpretation of MS/MS spectra and MS BLAST alignments with corresponding peptides. X are unidentified amino acid residues, L stands for both Leu and Ile residues; B stands for a generic trypsin cleavage site (Arg or Lys); sequences in brackets present isobaric combinations of amino acid residues, which could not be distinguished because of the absence of the corresponding fragment ions in the mass spectrum. All peptide sequence candidates from all fragmented precursors were merged into a single MS BLAST search string. Multiple sequence candidates per each fragmented precursor were allowed. Peptides 2, 4, 5, 3 and 6 (underlined) are contained in one putative exon derived from sequence FE8.
| 1 | 1185.6 | 3 | 3553.8 | SNVLYGPDTPTLSQSLGNS | Query: NVLYGPDTPTLSQS | CEACAM8 |
| NVLYGPD PT+S S | P31997 | |||||
| Sbjct: NVLYGPDAPTISPS | H. sapiens | |||||
| 2 | 693.3 | 3 | 2076.9 | BXXTVESVPPNAAEGKDALLR | Query: TVESVPPNAAEGKDALL | CEACAM8 |
| 1039 | 2 | T+E VP NAAEGK+ LL | P31997 | |||
| Sbjct: TIEAVPSNAAEGKEVLL | H. sapiens | |||||
| 3 | 553.2 | 2 | 1104.4 | BVTTPGPAYSGR | Query: TPGPAYSGR | CEACAM8 |
| TPGPAYS R | P31997 | |||||
| Sbjct: TPGPAYSNR | H. sapiens | |||||
| 4 | 656.8 | 4 | 2623.2 | B [VL]LPGDTASLTWFK [W/GE/AD/SV]TVLPXXK | Query: WFKGETV | CEACAM8 |
| 875.4 | 3 | W+KGETV | P31997 | |||
| Sbjct: WYKGETV | H. sapiens | |||||
| 5 | 539.2 | 2 | 1076.4 | BLLLYVLDTK | Query: BLLLYVLDT | Q9NOP7 |
| +++ YV+ T | CEA protein | |||||
| Sbjct: RIIGYVIAT | P. hamadryas | |||||
| 6 | 425.2 | 2 | 848.4 | BFETALLR | No match | |
| 7 | 386.2 | 2 | 770.4 | BTVPDSPR | No match |
FE8 putative exon
SLLAFWNPPTTAQVTVESVPPNAAEGKDALLRVLNLPGDTASLTWFKGETVLPTHKILLYVIDTKITTPGPAYSGRETIY PNGSLLFQNITLNDTGSYILQIINQKFETALVRGQLQVFRE